Skip to Content

Methylergonovine Pregnancy and Breastfeeding Warnings

Methylergonovine is also known as: Methergine

Methylergonovine Pregnancy Warnings

Methylergonovine has been assigned to pregnancy category C by the FDA. Animal reproductive studies have not been reported. There are no controlled data in human pregnancy. Use of methylergonovine is contraindicated during pregnancy because of its uterotonic effects.

See references

Methylergonovine Breastfeeding Warnings

Methylergonovine may be administered orally for a maximum of 1 week postpartum to control uterine bleeding. Recommended dosage is 0.2 mg orally 3 or 4 times daily. At this dosage level a small quantity of drug appears in human milk. Mothers should not breast-feed during treatment with methylergonovine and for at least 12 hours after administration of the last dose. Milk secreted during this period should be discarded.

See references

References for pregnancy information

  1. "Product Information. Methergine (methylergonovine)." Allscripts Healthcare Solutions, Chicago, IL.

References for breastfeeding information

  1. "Product Information. Methergine (methylergonovine)." Allscripts Healthcare Solutions, Chicago, IL.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.